Protein sequencing and next-generation proteomics by Quantum-Si

  • Mykhailo Ihnatenko
  • 09.10.2026
Proteus technology advances with new amino acid detection by Quantum-Si
Quantum-Si has announced the successful detection of another amino acid on its Proteus platform. This milestone brings the company one step closer to achieving the ability to detect all 20 ...
  • Yulia Slavina
  • 06.08.2026
Quantum-Si schedules August 13 earnings call to report second quarter 2026 results
Quantum-Si has announced that its next earnings call will take place on August 13. President and Chief Executive Officer Jeff Hawkins and Chief Financial Officer Jeff Keyes are expected to ...
  • Dmytro Kharkov
  • 02.07.2026
Quantum-Si investigates proteins teaching new drug targets in cancer treatment
Quantum-Si advances research into how proteins could provide insight for developing self-targeted oncology treatments. The company suggests that leveraging a protein's own biology to undermine ...
  • Yulia Slavina
  • 13.06.2026
Quantum-Si previews single-molecule protein sequencing to identify subtle amino acid changes
Quantum-Si will present its innovative single-molecule protein sequencing technology at the European Society of Human Genetics (ESHG) conference. The company aims to demonstrate how this ...
  • Elena Nikulina
  • 03.06.2026
ASMS event spotlights Quantum-Si collaboration on cutting edge PTM detection data
Quantum-Si is in the spotlight at the ASMS conference today as collaborators from the University of Virginia, including Dr. G Sheynkman and Dr. Natchanon Sittipongpittaya, present their latest ...
  • Oleg Tkachenko
  • 19.05.2026
Quantum-Si CEO Jeff Hawkins to speak at H.C.Wainwright BioConnect Investor Conference
Quantum-Si announced that its CEO Jeff Hawkins will participate in a fireside chat during the H.C.Wainwright 4th Annual BioConnect Investor Conference. The company is offering a live webcast for ...